- Home
- SVRE vs PRFX Comparison
SVRE vs PRFX Comparison
Compare SVRE & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRE | PRFX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.8M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SVRE | PRFX |
|---|---|---|
| Price | $0.92 | $1.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.9K | ★ 87.2K |
| Earning Date | 12-21-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $580,536.00 | N/A |
| Revenue This Year | $453.30 | N/A |
| Revenue Next Year | $106.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.19 | N/A |
| 52 Week Low | $0.77 | $0.80 |
| 52 Week High | $63.60 | $16.63 |
Technical Indicators
Market Signals| Indicator | SVRE | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 38.69 | 52.79 |
| Support Level | $0.86 | $0.91 |
| Resistance Level | $0.98 | $0.98 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 53.94 | 88.85 |
Price Performance
Historical ComparisonAbout SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.